0000096943-17-000075.txt : 20170511
0000096943-17-000075.hdr.sgml : 20170511
20170511180151
ACCESSION NUMBER: 0000096943-17-000075
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170505
FILED AS OF DATE: 20170511
DATE AS OF CHANGE: 20170511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TELEFLEX INC
CENTRAL INDEX KEY: 0000096943
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 231147939
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 E SWEDESFORD RD
STREET 2: SUITE 400
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 610-225-6800
MAIL ADDRESS:
STREET 1: 550 E SWEDESFORD RD
STREET 2: SUITE 400
CITY: WAYNE
STATE: PA
ZIP: 19087
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deren John
CENTRAL INDEX KEY: 0001706189
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05353
FILM NUMBER: 17835694
MAIL ADDRESS:
STREET 1: 550 E. SWEDESFORD ROAD
STREET 2: SUITE 400
CITY: WAYNE
STATE: PA
ZIP: 19087
3
1
wf-form3_149454009565236.xml
FORM 3
X0206
3
2017-05-05
0
0000096943
TELEFLEX INC
TFX
0001706189
Deren John
C/O 550 E. SWEDESFORD ROAD
SUITE 400
WAYNE
PA
19087
0
1
0
0
VP & Chief Accounting Officer
Common Stock
3881
D
Common Stock
4.203
I
By 401(k) Trustee
Stock Option / (Right to Buy)
79.48
2023-07-29
Common Stock
1258.0
D
Stock Option / (Right to Buy)
101.12
2024-02-26
Common Stock
988.0
D
Stock Option / (Right to Buy)
121.0
2025-02-25
Common Stock
1950.0
D
Stock Option / (Right to Buy)
144.79
2026-03-01
Common Stock
3543.0
D
Stock Option / (Right to Buy)
191.18
2027-02-28
Common Stock
3645.0
D
Represents the total of (a) 2,344 shares held directly by the reporting person; (b) 572 shares underlying a restricted stock award that was granted on 2/25/2015; (c) 544 shares underlying a restricted stock award that was granted on 3/1/2016; and (d) 421 shares underlying a restricted stock award that was granted on 2/28/2017. Each restricted stock award vests in its entirety on the third anniversary of the grant date.
Total number of shares is based on a plan statement dated as of May 5, 2017.
This stock option, which was granted on 7/29/2013 and provided the reporting person the right to purchase up to 5,906 shares, became exercisable for one-third of the shares on each of 7/29/2014, 7/29/2015 and 7/29/2016. A portion of this stock option was previously exercised.
This stock option, which was granted on 2/26/2014 and provided the reporting person the right to purchase up to 5,664 shares, became exercisable for one-third of the shares on each of 2/26/2015, 2/26/2016 and 2/26/2017. A portion of this stock option was previously exercised.
This stock option, which was granted on 2/25/2015 and provided the reporting person the right to purchase up to 5,850 shares, became exercisable for one-third of the shares on each of 2/25/2016, 2/25/2017 and 2/25/2018. A portion of this stock option was previously exercised.
This stock option, which was granted on 3/1/2016 and provided the reporting person the right to purchase up to 5,314 shares, became exercisable for one-third of the shares on each of 3/1/2017, 3/1/2018 and 3/1/2019. A portion of this stock option was previously exercised.
Exercisable for one-third of the shares on each of 2/28/2018, 2/28/2019 and 2/28/2020.
Remarks:
Note: Also see attached Exhibit EX-24 Power of Attorney.
Daniel V. Logue w/POA for John Deren
2017-05-11
EX-24
2
poaderen-2017.txt
POWER OF ATTORNEY - DEREN
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby
constitutes and appoints each of James
J. Leyden, Daniel V. Logue, Dwayne A. Ritchie or Victoria C.
Alff signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1)execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of
Teleflex Incorporated (the Company), Forms 3, 4, and 5
in accordance with Section 16(a)of the Securities Exchange
Act of 1934 and the rules thereunder;
(2)do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to
complete and execute any such Form 3, 4, or 5, complete
and execute any amendment or amendments thereto, and
timely file such form with the United States Securities
and Exchange Commission and any stock exchange or similar
authority, which actions shall include, without limitation, all
actions required to obtain new or replacement EDGAR access
codes required to submit Form 3, 4 and 5 filings with the SEC;and
(3) take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of
such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the undersigned,
it being understood that the documents executed by
such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as
such attorney-in-fact may approve in such attorney-
in-fact's discretion.
The undersigned hereby grants to each such attorney-
in-fact full power and authority to do and perform
any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as
fully to all intents and purposes as the undersigned
might or could do if personally present, with full
power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein
granted.
The undersigned acknowledges that the foregoing
attorneys-in-fact,in serving in such capacity at
the request of the undersigned, are not assuming,
nor is the Company assuming, any of the
undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required
to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in
securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this
8th day of May 2017.
/s/ John Deren
John Deren